Biocelect welcomes Australia's Therapeutic Goods Administration (TGA) approval of KODATEF (tafenoquine); the first malaria prevention drug approved in Australia in more than two decades
top of page
© 2024 Biocelect
Australian Office: Level 4, 143 Macquarie Street, Sydney NSW 2000, Australia
Registered Office Australia: Level 29, 66 Goulburn Street, Sydney NSW 2000, Australia
Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand
Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,
sea and community. We pay our respects to the Elders, emerging, past and present.
Last Updated 26th August 2024
bottom of page
Comentários